Innovative Medicine
-
-
-
-
-
-
New Study Shows Circulating Tumor Cell Enumeration – as Part of Composite Biomarker Panel –May Serve as a Surrogate for Efficacy Response in Metastatic Castration-Resistant Prostate Cancer
First study to find patients with unfavorable risk profile at 12 weeks have worse prognosis and should be considered for alternative treatments -
Japanese Health Authority Approves SOVRIAD™ For The Treatment Of Genotype-1 Chronic HCV Infection
Japan is the first country in the world where SOVRIAD™ is approved -
-
Janssen Healthcare Innovation Launches Care4Today™ Mobile Health Manager 2.0
Free two-way secure messaging platform, mobile app and website introduces new Care4Charity™ and Care4Family™ features to motivate users to take medications on schedule and support caregivers